CHAOJU EYE CARE News

Chaoju Ophthalmology (2219.HK) 2024 Interim Results Report Review: Steady growth in basic consumer ophthalmology helps the company develop with steady growth, cost reduction and efficiency

Sep 1, 2024 00:00

Chaoju Ophthalmology (2219.HK): 1H performance highlights resilience, 2H consumer ophthalmology may gain strength

htscAug 30, 2024 00:00

Chaoju Ophthalmology (02219.HK): Strong mergers and acquisitions in basic consumer ophthalmology combine rapid expansion

Apr 10, 2024 00:00

Chaoju Ophthalmology (2219.HK): Looking forward to steady revenue growth in 24 years

Apr 10, 2024 00:00

Chaoju Ophthalmology (02219.HK): Performance is basically in line with expectations, and the store network continues to expand

Apr 6, 2024 00:00

Chaoju Ophthalmology (2219.HK) 2023 Annual Performance Report Review: Basic Consumer Ophthalmology Dual Growth Mergers and Acquisitions New Hospitals Dual Drivers

Mar 29, 2024 07:36

Chaoju Ophthalmology (2219.HK): Strong growth in basic consumer ophthalmology, new hospitals continue to climb

Mar 28, 2024 16:51

Chaoju Ophthalmology (2219.HK): North China's leading ophthalmology medical leader promotes endogenous epitaxial growth

Feb 28, 2024 00:00

Review of Chaoju Ophthalmology (2219.HK) Interim Report: Post-epidemic recovery performance is obvious, and basic consumer ophthalmology has both increased

Sep 28, 2023 18:22

Chaoju Ophthalmology (02219.HK) 2023 Interim Report Review: Business Recovery Is Clearly Rooted in North China and the Yangtze River Delta

Sep 22, 2023 19:52

Chaoju Ophthalmology (02219.HK): 1H23 performance is in line with expectations and profitability is gradually improving

中金公司Sep 10, 2023 00:00

Chaoju Ophthalmology (2219.HK) Company Review: Performance Recovery, Profitability, and Steady Progress in Strategic Expansion

國金證券Aug 30, 2023 00:00

Chaoju Ophthalmology (02219.HK): Deeply involved in North China radiating both internal and external training in Jiangsu and Zhejiang, with outstanding profits

國金證券Jul 20, 2023 00:00

Chaoju Ophthalmology (2219.HK): Fundamentals are firmly looking forward to a steady recovery in 23 years

華安證券Mar 31, 2023 00:00

Chaoju Ophthalmology (2219.HK): Results in '22 are under pressure and we are optimistic about the return of patients in '23

華泰證券Mar 29, 2023 00:00

Big Bank Ratings | CICC: For the first time, Chaoju Ophthalmology's target price of “outperforms the industry” rating is HK$7.68

Gelonghui FinanceMar 10, 2023 17:45

Chaoju Ophthalmology (2219.HK): The growth of the ophthalmology industry determines the expansion of endogenous epitaxial expansion

國元國際Feb 14, 2023 00:00

Chaoju Ophthalmology Clinic (2219.HK) first coverage: deepening expansion outside of Inner Mongolia

西部證券Oct 25, 2022 00:00

Chaoju Ophthalmology (2219.HK): Mergers and acquisitions are imminent in North China

華安證券Sep 26, 2022 00:00

Chaoju Ophthalmology Clinic (2219.HK): The number of patients affected by the epidemic may accelerate 2H22

華泰證券Aug 31, 2022 00:00